Page last updated: 2024-11-04

rofecoxib and Osteosarcoma

rofecoxib has been researched along with Osteosarcoma in 1 studies

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbey, S1
Goossens, L1
Taverne, T1
Cornet, J1
Choesmel, V1
Rouaud, C1
Gimeno, G1
Yannic-Arnoult, S1
Michaux, C1
Charlier, C1
Houssin, R1
Hénichart, JP1

Other Studies

1 other study available for rofecoxib and Osteosarcoma

ArticleYear
Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor.
    Bioorganic & medicinal chemistry letters, 2002, Mar-11, Volume: 12, Issue:5

    Topics: Animals; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors;

2002